GenSight Biologics Company
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.
Investors
Headquarters:
United States
Founded Date:
2018.0
Estimated Revenue:
€1.34 MillionAccording
Investor Type:
Healthcare Company
Technology:
Advanced BioTech R&D
Employee Number:
6
Industry:
Biotechnology, Heath and Wellness Technology